Belmont Global Advisors’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	$468K	Sell	150,000 -250,000	-63%	-$780K	0.44%	36
2016 Q2	$680K	Sell	400,000 -82,000	-17%	-$139K	0.65%	23
2016 Q1	$868K	Buy	482,000 +317,000	+192%	+$571K	0.88%	16
2015 Q4	$556K	Buy	+165,000	New	+$556K	0.72%	36